Jaguar Health (JAGX) Stock: Buy, Sell, or Hold?
JAGX - Jaguar Health, Inc.
$3.66
-0.29 (-7.34%)
▼
5d:
-52.47%
30d:
+401.44%
90d:
+30.25%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When JAGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: JAGX is down 52.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: JAGX is down 52.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: JAGX is currently trading at $3.66, which is considered fair relative to its 30-day fair value range of $-3.17 to $10.02.
Technical Outlook: Technically, JAGX is showing sideways momentum. Immediate support is located at $2.48, while resistance sits at $41.53. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: JAGX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $262.50 (+7072.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JAGX is showing sideways momentum. Immediate support is located at $2.48, while resistance sits at $41.53. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: JAGX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $262.50 (+7072.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$-3.17 -
$10.02
Company Quality Score
37/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
39.5%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 7072.1% below Wall St target ($262.50)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-3.17 -
$10.02
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.48
Resistance Level
$41.53
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.39
Wall Street Target
$262.50
(+7072.1%)
Revenue Growth (YoY)
-58.9%
Profit Margin
-130.8%
Share & Embed Analysis
Last updated: October 03, 2026 3:03 PM ET
Data refreshes hourly during market hours. Next update: 4:03 PM
Data refreshes hourly during market hours. Next update: 4:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JAGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 62 BUY |
